TAK Stock Summary and Trading Ideas (Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) | NYSE:TAK)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) trades on the NYSE stock market under the symbol TAK.

As of May 17, 2024, TAK stock price declined to $13.22 with 998,545 million shares trading.

TAK has a beta of 0.45, meaning it tends to be less sensitive to market movements. TAK has a correlation of 0.11 to the broad based SPY ETF.

TAK has a market cap of $41.48 billion. This is considered a Large Cap stock.

In the last 3 years, TAK stock traded as high as $17.56 and as low as $12.28.

The top ETF exchange traded funds that TAK belongs to (by Net Assets): PPH, APIE, AVDE, VEU, PTIN.

TAK has underperformed the market in the last year with a price return of -18.8% while the SPY ETF gained +29.1%. TAK has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.6% and -1.1%, respectively, while the SPY returned +6.3% and +3.6%, respectively.

TAK support price is $13.18 and resistance is $13.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TAK stock will trade within this expected range on the day.